MARKET

HSDT

HSDT

Helius Med Technologies Inc
NASDAQ
5.00
-0.11
-2.15%
Opening 09:30 04/19 EDT
OPEN
5.00
PREV CLOSE
5.11
HIGH
5.00
LOW
5.00
VOLUME
2.19K
TURNOVER
0
52 WEEK HIGH
14.44
52 WEEK LOW
4.290
MARKET CAP
4.44M
P/E (TTM)
-0.3434
1D
5D
1M
3M
1Y
5Y
*Helius Medical Technologies to Offer Stock and Warrants
Dow Jones · 3d ago
Helius Medical files to sell Class A common stock, warrants
Seeking Alpha · 3d ago
Weekly Report: what happened at HSDT last week (0408-0412)?
Weekly Report · 4d ago
Weekly Report: what happened at HSDT last week (0401-0405)?
Weekly Report · 04/08 11:08
HELIUS MEDICAL TECHNOLOGIES - ON APRIL 4, RECEIVED NOTICE FROM NASDAQ STATING CO NO LONGER COMPLIES WITH MINIMUM STOCKHOLDERS' EQUITY REQUIREMENT
Reuters · 04/05 21:02
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Protara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. Candel Therapeutic shares moved upwards by 25.93% during the session. The company's market cap stands at $236.5 million.
Benzinga · 04/05 12:09
EC, ABAT and BORR among pre-market losers
On the Move EC, ABAT and BORR among pre-market losers. Keyarch Acquisition Corp (KYCH) reports fourth quarter and year-end 2023 financial results and recent business highlights. ABIO, XTIA, CGC, HSDT, ONMD, KYCH and ABAT also lose ground.
Seeking Alpha · 04/04 12:25
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tevogen Bio Holdings stock rose 85.5% to $4.86 during Thursday's pre-market session. Candel Therapeutics (NASDAQ:CADL) shares rose 27.97% and Healthcare Triangle stock rose 23.56% in the same session. Losers Telesis Bio (NASdaq:TBIO) stock fell 11.8% during the session. Q4 earnings came out today.
Benzinga · 04/04 12:09
More
About HSDT
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

Webull offers Helius Medical Technologies Inc stock information, including NASDAQ: HSDT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSDT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HSDT stock methods without spending real money on the virtual paper trading platform.